News > Pharmaceuticals

13th March 2018

A flu vaccine in pill form has been created by Welsh scientists

Scientists at Cardiff University have created the world’s first vaccination in pill form – a breakthrough which could “revolutionise” patient care and save the NHS money.

05th February 2018

Job Opportunity: Santander, Sub-Sector Specialist, Manufacturing (Chemical, Pharmaceuticals & Life sciences)

Santander are currently have an exciting opportunity for a Sub-Sector Specialist to join the Manufacturing sector, with a specific focus and expertise across Chemical, Pharmaceuticals and Life sciences.
08th January 2018

Cardiff Met Co-Creates New Anti-Cancer Treatment

Cardiff Metropolitan University has been instrumental in the development of a new anti-cancer agent that has the potential to offer a novel and valuable first-in-class treatment option for cancer.
05th January 2018

Cardiff University scientists’ drugs test breakthrough

Scientists in Wales have helped develop a technique to streamline production of new drugs to detect if they could become ineffective or even harmful.
27th November 2017

Pharma deals are ‘vote of confidence’, says government

The government has said two deals to invest in the UK's biotech industry illustrate confidence in its industrial strategy, which it published on Monday.
03rd November 2017

Five new medicines to be fast-tracked annually to NHS patients

The government has announced a plan to speed up the time it takes for new, life-changing medicines to reach patients.
25th October 2017

New cancer drug to be available in Wales

Nivolumab, a new life-extending drug to treat some forms of lung cancer is to be made routinely available in Wales, the Welsh Goverment has announced.
31st August 2017

First cancer ‘living drug’ gets go-ahead

The US has approved the first treatment to redesign a patient's own immune system so it attacks cancer.
29th August 2017

Anti-inflammatory drug ‘cuts heart attack risk’

Anti-inflammatory drugs could cut the risk of heart attacks and strokes, a study of 10,000 patients suggests.

22nd August 2017

Wynne-Jones IP – Why an IP strategy is vital to the pharmaceutical industry

An effective intellectual property (IP) strategy is integral to preserving innovation and continuous progression in the pharmaceutical industry.